Ranbaxy Australia Pty Ltd has
said it did not lodge a complaint
with the Australian Competition
and Consumer Commission (ACCC)
about Pfizer.
The company said reports on
the ACCC’s case against Pfizer for
alleged anti-competitive activities
(PD 14 Feb) had suggested it
resulted from a Ranbaxy complaint,
but this was incorrect.
“At the request of the ACCC,
RAPL has provided information in
regards to our company’s launch
and on-going promotion of Trovas
(atorvastatin).”The above article was sent to subscribers in Pharmacy Daily's issue from 24 Feb 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 24 Feb 14
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.